See Jewel Kai Lin, Liu Xinyao, Canfora Federica, Moore Caroline, McCullough Michael, Yap Tami, Paolini Rita, Celentano Antonio
Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 5 Via Pansini, 80138 Naples, Italy.
J Pers Med. 2023 Oct 23;13(10):1520. doi: 10.3390/jpm13101520.
Micronutrients are vital for general and oral health, and their potential anti-cancer properties are documented. We explore beneficial vitamins for oral potentially malignant disorders (OPMDs) and oral cancer (OC), assessing the therapeutic impacts of essential vitamin supplementation.
We systematically review evidence on vitamin supplementation's therapeutic effects for OPMDs and OC. Relevant studies were identified through comprehensive searches of MEDLINE, Evidence-Based Medicine, and Web of Science until 16 May 2023. All studies underwent risk of bias using criteria modified from the Office of Health Assessment and Translation (OHAT) tool.
We analysed 80 papers. Vitamin K, studied in vitro, shows promising therapeutic potential. Vitamin C, investigated in vivo (animals and humans), demonstrated mixed animal results and generally positive human trial effects. Vitamin A's efficacy varied, with positive monotherapy or adjunct effects. Vitamins B and D showed therapeutic benefits. Oral cancer research was extensive, with a focus on oral lichen planus and oral leukoplakia among the 11 OPMDs. All bias levels were reported in 'selective reporting' and 'performance', except for "definitely high" in the 'selection', 'detection', and 'attrition/exclusion' domains.
Evidence of vitamin interventions for OPMDs and OC ranges from mixed to promising. Standardizing the study design and outcomes would enhance future research.
微量营养素对全身健康和口腔健康至关重要,其潜在的抗癌特性也有文献记载。我们探讨对口腔潜在恶性病变(OPMDs)和口腔癌(OC)有益的维生素,评估补充必需维生素的治疗效果。
我们系统回顾了关于维生素补充剂对OPMDs和OC治疗效果的证据。通过全面检索MEDLINE、循证医学和科学网,直至2023年5月16日,确定相关研究。所有研究均使用从健康评估与转化办公室(OHAT)工具修改而来的标准进行偏倚风险评估。
我们分析了80篇论文。体外研究的维生素K显示出有前景的治疗潜力。体内(动物和人类)研究的维生素C,在动物实验中结果不一,在人体试验中总体显示出积极效果。维生素A的疗效各不相同,单一疗法或辅助疗法有积极作用。维生素B和D显示出治疗益处。口腔癌研究广泛,在11种OPMDs中重点关注口腔扁平苔藓和口腔白斑。除了“选择”“检测”和“失访/排除”领域为“肯定高”外,“选择性报告”和“实施”中的所有偏倚水平均有报告。
维生素干预OPMDs和OC的证据从不一到有前景不等。规范研究设计和结果将加强未来的研究。